BACKGROUND There has been no report on the clinical features or natural history of autoimmune hemolytic anemia (AIHA) in the Korean adult population. This study retrospectively analyzed the clinical characteristics and long-term outcomes of AIHA in the Korean adults. METHODS Patients newly diagnosed with AIHA between January 1994 and December 2010 at Chungnam National University Hospital were...

Individual lodgepole pines (Pinus contorta) were fertilized with urea at nitrogen (N) inputs equivalent to 0, 315, or 630 kg/ha. Four months after application of the fertilizer, inner bark tissue N concentrations were significantly higher in the trees that had received the low dose (315 kg/ha) fertilization treatment than in the control trees; trees that had received the high-dose treatment (63...

dryland winter wheat (triticum sativum l.) generally grown in rotation with fallow or chickpea (cicer arietinum l.) constitutes a major crop in the west region of iran. information is limited on the success of more intensive dryland cropping systems while applying conservation tillage management. an experiment was conducted to determine the effect of five tillage systems on soil physical proper...

We report the results of four cycles of rituximab therapy in eleven patients with chronic warm antibody type autoimmune hemolytic anemia (AIHA) and six patients with chronic idiopathic thrombocytopenia (ITP). The overall response rate was 64% in the AIHA group (3 complete responses and 4 partial responses) and 83% in the ITP group (4 complete responses, 1 partial response). Responses in AIHA pa...

OBJECTIVE To present and discuss the treatment of autoimmune hemolytic anemia (AIHA). METHODS The medical records of all patients (n=19) diagnosed in a tertiary hematology center between 1999 and 2010 were retrospectively reviewed. RESULTS Median age at diagnosis of AIHA was 5 years (range: 4 months-17 years). In all, 13 patients had primary (idiopathic) AIHA, whereas 2 had primary Evans Sy...

Standard treatment for autoimmune hemolytic anemia (AIHA) due to warm antibodies includes combinations of glucocorticoids, immunosuppressive drugs (mainly azathioprine) and splenectomy. Patients who are refractory or intolerant to these therapies constitute an important therapeutic challenge. Rituximab, an anti-CD20 chimeric monoclonal antibody, can effectively deplete B-cells and is commonly u...

Autoimmune hemolytic anemia (AIHA) is a clinically relevant complication after allogeneic hematopoietic stem cell transplantation (HSCT). Currently, there is no established consensus regarding the optimal therapeutic approach. Whether AIHA contributes to increased mortality is still somewhat controversial.We investigated the incidence, risk factors, and outcome of post-transplant AIHA in 265 co...

UNLABELLED A female in the Netherlands with severe autoimmune hemolytic anemia (AIHA) was treated with conventional corticosteroid (2 mg/kg/d in divided doses) and blood transfusions for 18 months without improvement. The presented patient responded to megadose methylprednisolone (MDMP) 30 mg/kg/d for 3 d, followed by 20 mg/kg for 4 d, and subsequently 10, 5, 2, and 1 mg/kg/d each for 1 week. ...